Ischemic optic neuropathy occurs when blood flow to the optic nerve is suddenly reduced, most often linked to underlying vascular risk factors such as high blood pressure and diabetes, which are increasingly common across Zimbabwe. The resulting vision loss is typically sudden and painless. While managing the underlying vascular risk factors remains the medical priority, some Zimbabweian patients explore stem cell therapy as an additional option to help support the affected optic nerve.
Vascular risk factors linked to ischemic optic neuropathy — hypertension and diabetes — are widespread across Zimbabwe, yet specialized neuro-ophthalmology evaluation for the resulting optic nerve damage is limited outside major cities. Patients are often referred abroad to explore regenerative options once their underlying vascular condition is under medical management.

Associate Professor, Vitreo-Retina Surgeon. 10+ Years Experience

Senior Consultant Ophthalmologist & Eye Surgeon· 26+ yrs experience

Consultant Ophthalmologist & Eye Surgeon, MD, DO .16+ Years Experience
Suitability depends on the stage and cause of the condition. Before travelling, our team reviews:

I am very satisfied with the services at Stem Cell Cure. The team is very professional and knowledgeable. They provided good guidance and ensured every step of the process was smooth and comfortable

Highly trustworthy! From consultation to follow-up, the team was responsive and dedicated. Excellent facilities and patient-focused approach!
“No. Managing the underlying vascular risk factors remains essential and is handled by your treating physician. Stem cell therapy addresses the optic nerve tissue itself, not the underlying vascular condition.”
“Earlier evaluation generally allows a clearer picture of remaining optic nerve function, though our team can review reports at any stage.”
” OCT scan, visual field test, and recent blood pressure/diabetes records, along with details of when vision loss occurred.”

We would love to hear from you! Please fill out the form below.